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Abstract     
Cyclization of 1,2:3,4-di-O-isopropylidene-α-D-galacto-1,6-hexodialdo-1,5-pyranose 
benzoylhydrazone using acetylating mixtures led us to the corresponding (2R)- and (2S)-5-
phenyl-1,3,4-oxadiazoline derivatives.  The same conditions applied to the semicarbazone 
produced the 5-methyl-1,3,4-oxadiazoline derivative as the main compound, which is formed 
with acetylating mixtures even at room temperature. X-Ray analysis and NMR techniques were 
used to determine the stereochemistry of the new asymmetric centers.   
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Introduction 
 
The synthesis of 3-N-acyl-1,3,4-oxadiazolines is a well-known reaction and there is a lot of 
information on this field, however in recent years the number of publications has increased due 
to the great potential of this heterocyclic ring as chemotherapeutic agent.1,2 Nevertheless, some 
aspects of heterocyclization reaction are not well known.  
Looking for new potential biological agents, we studied the differences between 
heterocyclization of acylhydrazone and semicarbazone obtained from protected carbohydrate 
derivatives. Also, a hypothesis for their different behavior is proposed. 
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Results and Discussion 
 
In this paper we analyzed the behavior of 1,2:3,4-di-O-isopropylidene-α-D-galacto-1,6-
hexodialdo-1,5-pyranose benzoylhydrazone (1) and 1,2:3,4-di-O-isopropylidene-α-D-galacto-
1,6-hexodialdo-1,5-pyranose semicarbazone (2) under acetylating conditions, in order to obtain 
the corresponding 3-N-acetyl-5-phenyl-2-[5-(1,2:3,4-di-O-isopropylidene-α-L-arabino-
pyranosyl)]-1,3,4-oxadiazolines (3) and 3-N-acetyl-5-methyl-2-[5-(1,2:3,4-di-O-isopropylidene-
α-L-arabinopyranosyl)]-1,3,4-oxadiazolines (4). In Scheme 1, we show the acetylation reaction 
and the obtained products. 
 
 
 
Scheme 1. Synthesis of compound 3 and 4. 
 
Semicarbazone derivative 2 was synthesized by reaction of 1,2:3,4-di-O-isopropylidene-α-D-
galacto-1,6-hexodialdo-1,5-pyranose with semicarbazide hidrochloride and sodium bicarbonate 
in ethanolic solution. After removal of salts the crude product was obtained as a syrup, which 
crystallized from methanol. The 1H NMR analysis performed on the syrup indicated that there is 
only one isomer, unlike benzoyl hydrazone 13, which was synthesized as a mixture of anti:syn 
isomers in a 3:1 relationship. We performed a single crystal x-ray diffraction analysis of 2 and 
found an anti configuration for the C=N bond, but also presented a deviation respect to the 
expected zig-zag conformation. This orientation of the carbonyl group relative to the N=C group 
enables the formation of intermolecular hydrogen bonds, contributing to the ordering of the 
molecules and subsequent crystallization (Figure 1).  
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Figure 1. Drawing of the crystal packing of compound 2. 
 
Acetylation of compound 1  using acetic anhydride in pyridine and reflux, yielded  (2R)- and 
(2S)-3-N-acetyl-5-phenyl-2-[5-(1,2:3,4-di-O-isopropylidene-α-L-arabinopyranosyl)]-1,3,4-
oxadiazolines 3a and 3b in a nearly 1:1 relationship. Once purified, the compound with higher 
Rf crystallized. After the X-ray analysis, we found S stereochemistry for the new asymmetric 
center. (Figure 2).  
 
 
 
Figure 2. Ellipsoid plots (40% probability level) of compound 2 and 3b. 
 
Both molecules (2 and 3b) share their leftmost part (Figure 2, primed labels), and thus have a 
number of characteristics in common: in both units the fused dioxolane cycles prevent the 
pyranose ring from assuming a regular conformation; it exhibits instead a highly distorted twist-
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boat geometry clearly evidenced through the comparison of some selected torsion angles, viz., 
C2’-C3’-C4’-C5’: 12.6(2)º (3b) or -3.8 (2) (implying that the C2’-C3’ and C4’-C5’ bonds are 
nearly eclipsed) vs. C2’-C1’-O1’-C5’: 41.3(2)º (in 3b), 47.4(1)º (in 2) (showing  that the C2’-
C1’ and O1’-C5’ bonds are far from coplanar).  
The two five membered dioxolane rings exhibit in turn clear envelope conformations with 
“slap-atoms” O3’, O5’ in 3b and O3’, C9’ in 2 being 0.42(1), 0.35(1), 0.49(1) and 0.48(1) Å, 
respectively, away from the L.S. planes defined by the remaining four atoms. Differences reside 
in the rightmost part of the structures. 
In the case of 3b the 1,3,4-oxadiazoline ring is almost planar with only a slight puckering 
into an envelope shape, atom C2 being  0.14(1) Å away from the plane defined by the remaining 
four atoms (torsion angle N3-N4-C5-O1: 1.6(1)º) ). The terminal phenyl group appears rotated 
around the C5-C6 bond by 13.0(1)º. The final model ends up having six asymmetric carbon 
centers, C1’, C2’, C3’, C4’, C2, C5’. The absolute configuration (R at C1’, C2’ and S at the 
remaining four asymmetric sites) was figured out from the configuration of carbon centers of 
known stereochemistry. 
Since there are no active N-H or O-H donors in the molecule, no strong H-bonding 
interactions exist in the structure. There is only a weak non classical C4’-H4’...O1’i contact 
(H4’…O1’i: 2.50 Å, C4’…O1’i: 3.264(4) Å, C4’-H4’…O1’i: 134º¸ (i): 2-x, 1/2+y, 1-z) 
generating a weakly linked chain which runs along b, threaded by the monoclinic twofold screw 
axis. Structure 2 differs from 3b in that there are no rings in this part of the structure, while there 
are active N-H donors giving raise to a strong H-bond N4---H4A…O3ii (H4A…O3ii: 2.05 Å, 
N4…O3ii: 2.958 Å, N4---H4A…O3ii: 167º¸ (ii): -1/2+x,3/2-y,-z) generating a strongly linked 
chain, also threaded by a twofold screw axis (this time along a). 
Compounds 3a and 3b were characterized spectroscopically, and a NOESY experiment was 
performed for 3a.  In this experiment, the most relevant cross peak correlations were H4-H2(Het) 
and –CH3(C)-Ph, which confirmed the 2R stereochemistry for compound 3a. The observed 
correlations are depicted in Figure 3.  
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Figure 3. Cross correlations found in the NOESY experiment for compound 3a. 
 
When compound 2 was subjected to the same reaction conditions methyloxadiazolines 4a (R) 
and 4b (S) were obtained, although some byproducts were also detected. In order to perform a 
cleaner reaction, we carried out a microwave assisted synthesis, using the same reagents and 
heating at 140 °C during 60 minutes and we obtained 4a and 4b with better yields. 
Stereochemistry of compound 4a and 4b were determined by comparison with NMR data of 
compounds 3a and 3b. Conditions, yields, and R:S relationship for compounds 3 and 4 are shown 
on Table 1. After 15 min of irradiation, we observed the formation of both oxadiazolines (4a and 
4b) and the presence of a third compound (5), which disappears after 60 min of irradiation. The 
chromatographic behavior of 5 is similar to that observed for the main byproduct of the thermal 
treatment. Once isolated, compound 5 was identified as 4-N-acetyl-1,2:3,4-di-O-isopropylidene-
α-D-galacto-1,6-hexodialdo-1,5-pyranose semicarbazone.  
 
Table 1. Conditions for synthesis of compounds 3 and 4, yield, and R:S relationship. 
Compound Method Heating Yield R:S 
3a and 3b Thermal 1 h 94 % 1.1:1 
4a and 4b Thermal 3 h 52 % 1.3:1 
4a and 4b µwave 1 h 68 % 1:1.1 
 
Hang et al.4 proposed a mechanism for acylhydrazone cyclization via two different pathways, 
the direct and the indirect one. This latter route would generate the methyloxadiazoline as results 
of prolonged heating. When we treated semicarbazone 2 with acetic anhydride and pyridine at 
reflux, the product of direct cyclization was not observed and the main products were 
methyloxadiazolines (4a and 4b). When the same reaction was carried out at room temperature, 
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the formation of compound 5 and 4b was observed within two hours of reaction. After 60 hs the 
reaction was stopped and we could isolate the oxadiazoline 4b (6%) along with traces of 4a, 
compound 5 (13%), and the unreacted compound 2 (35%); meanwhile N2-acetyl or N2,N4-
diacetyl derivatives were not detected.  
These results demonstrated that the formation of methyloxadiazoline could not be attributed 
exclusively to the reaction temperature. Under these conditions, N4 would be the first acetylated 
nitrogen, since it is not sterically hindered, giving compound 5. The proposed reaction 
mechanism4 (Scheme 2) starts with a N2 acylation, followed by a cyclization assisted by acetic 
anhydride. Based on this hypothesis, we propose that, if some of N2 acetylation takes place, this 
derivative (6) can rearrange assisted by the N4 electron pair, and undergo cyclization at low 
temperature. If we assume that the mechanism is similar to the one proposed for 
thiosemicarbazones cyclization, via carbocation intermediate5 the result is the same. 
 
 
 
Scheme 2. Proposed cylization mechanism for semicarbazones 
 
According to our previous experiences on cyclization of sterically hindered 
thiosemicarbazones and acylhydrazones,6 the stereochemistry of the molecule can rule the side 
of attack of sulfur atom, but this influence was not observed for oxygenated derivatives. Other 
authors reported that predominance of R or S oxadiazoline isomer is a direct consequence of the 
acylhydrazone syn:anti relationship,4,7 but no R:S selectivity was observed for the oxadiazoline 
derivative because syn and anti isomers can be equilibrated by temperature or the presence of 
acetic acid.  
During cyclization of 2 at room temperature, acetic anhydride with excess of pyridine was 
used, so, isomerization of anti form of 2 could not take place, and the main heterocyclic 
compound obtained was 4b. Taking into account that the starting material was a single isomer 
we can conclude that the preferential formation of 4b is a consequence of the stereochemistry of 
C=N bond on compound 2. On the other hand, some calculations using molecular mechanics,8 
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showed that compound 4a is about 6 Kcal/mol more stable than 4b, so 4b must be a kinetic 
product meanwhile 4a must be the thermodynamic one. 
 
 
Conclusions    
 
Taking into account our experimental results, we can conclude that the cyclization of 
benzoylhydrazone 1 using acetic anhydride and pyridine at reflux, yielded 1,3,4-oxadiazoline 
derivatives (3a and 3b) as a mixture of syn:anti isomers. Under the same conditions, the 
semicarbazone 2 yields the methyloxadiazoline instead of the product of direct cyclization. This 
fact can be explained by the presence of the N4 electron pair, which promotes the loss of the 
carbamoyl group. Also, we performed the acetylation of compound 2 at room temperature and 
found that the cyclization takes place yielding preferentially 4b, which would be the kinetic 
reaction product. 
    
  
Experimental Section     
 
General. Elemental analysis was performed on an Exeter Analytical CE-440 elemental analyzer. 
Optical rotations were recorded at 20 °C on a Perkin Elmer 343 polarimeter. 1H, 13C NMR 
spectra were recorded on solution of CDCl3 on a Bruker AC-200 spectrometer, operating at 200, 
50 MHz respectively; or a Bruker AMX-500 spectrometer, operating at 500, 125 MHz 
respectively. Assignments of the 1H and 13C NMR spectra were confirmed with the aid of two 
dimensional techniques 1H, 13C (COSY, HSQC).  
Microwave-assisted synthesis was performed on an Anton Paar Monowave 300 microwave 
reactor with external surface sensor in a sealed reaction vessel. Chromatographic purifications 
were performed by flash column with Merck silica gel 60. The chemicals used in this work 
purchased from Aldrich and were used without further purification. 
X-ray data was collected on an Oxford Diffraction Gemini CCD S Ultra single crystal 
diffractometer using Mo Ka radiation (λ = 0.71073 Å).9 A multi-scan absorption correction was 
applied.10 The structure was solved by direct methods and refined by full-matrix least squares 
against F2 using all data.11 All non-H atoms were refined anisotropically, while H atoms were 
located at idealized positions with their displacement parameters riding on the values of their 
parent atoms. The general-purpose crystallographic program PLATON12 was used for the 
structure analysis and presentation of the results. The figures were drawn with XP.11   
 
1,2:3,4-Di-O-isopropylidene-α-D-galacto-1,6-hexodialdo-1,5-pyranose semicarbazone (2). 
To 1,2:3,4-di-O-isopropylidene-α-D-galacto-1,6-hexodialdo-1,5-pyranose 0.56 g (2.2 mmol) 
dissolved in 25 mL of ethanol, semicarbazide hydrochloride (0.27 g, 2.4 mmol) and sodium 
bicarbonate (0.20 g, 2.4 mmol) were added. The mixture was heated with magnetic stirring for 2 
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hs, filtered to eliminate the salt and evaporated. Te residue was suspended in dichloromethane, 
filtered, evaporated and dissolved in methanol. From this solution crystallizes compound 2. 
Colourless crystals, yield 75%, 0.520 mg; mp 221-223 °C; CCDC 894994; Rf: 0.42 in ethyl 
acetate; [α]D20 -1.5 (c 0.95, CHCl3); 1H NMR (500 MHz, CDCl3) δH 1.36, 1.37, 1.49, 1.58 (12 
H, four s, -C(CH3)2), 4.34 (1H, dd, 3JHH 2.1 Hz,  3JHH 7.9 Hz, H-4), 4.36 (1H, dd, 3JHH 2.5 Hz, 
3JHH 5.0 Hz, H-2), 4.39 (1H, dd, 3JHH 1.9 Hz, 3JHH 6.0 Hz, H-5), 4.66 (1H, dd, 3JHH 2.5 Hz, 3JHH 
7.9 Hz, H-3), 5.33 and 5.85 (2H, two broad s, -CONH2), 5.58 (1H, d, 3JHH 5.0 Hz, H-1), 8.95 
(1H, s, -CONH-); 13C NMR (125 MHz, CDCl3) δC 24.3, 24.9, 25.9, 26.2 (-C(CH3)2), 68.4 (C-5), 
70.3 (C-2), 70.6 (C-3), 73.0 (C-4), 96.2 (C-1) 108.9, 109.7 (-C(CH3)2), 141.1 (C-6), 157.4 
(C=O); Anal. calcd. for C13H21N3O6: %C, 49.52; %H, 6.71; %N, 13.33. Found %C, 49.33; %H, 
6.92; %N, 13.21.  
 
General synthetic procedure for thermal cyclization of compound 1 and 2. Compound 1 
(0.352 g, 0.9 mmol) or 2 (0.399 g, 1.3 mmol) were dissolved in pyridine (2.5 mL) and acetic 
anhydride (2.5 mL). The resulting mixture was refluxed (see Table 1) and then was left to reach 
room temperature. Once cold, some ethanol was added and the reaction medium was evaporated 
at reduced pressure, giving a glassy residue. The residue was purified using flash dry column on 
Silicagel G with mixtures of cyclohexane/acetone and obtained compounds 3a and 3b or 4a and 
4b. 
 
(2R)-3-N-Acetyl-5-phenyl-2-[5-(1,2:3,4-di-O-isopropylidene-α-L-arabinopyranosyl)]-1,3,4-
oxadiazoline 3a. Colorless syrup, Rf: 0.52 in 40% ethyl acetate/cyclohexane; [α]D20 0.82 (c 1.03, 
CHCl3); 1H NMR (500 MHz, CDCl3) δΗ 1.29 1.41, 1.48, 1.54 (12 H, four s, -C(CH3)2), 2.34 
(3H, s, -NCOCH3), 4.34 (1H, dd, 3JHH 2.6 and 3JHH 4.9 Hz, H-2) 4.44 (1H, broad s, H-5), 4.55  
(1H, dd, 3JHH 2.0 Hz and 3JHH 7.8 Hz, H-4), 4.69 (1H, dd, 3JHH  2.6 Hz and 3JHH 7.8 Hz, H-3), 
5.49 (1H, d, 3JHH  4.9 Hz, H-1), 6.43 (1H, broad s, HetH-2); 13C NMR (125 MHz, CDCl3) δC 
21.4 (-NCH3), 24.9, 25.0, 25.9, 26.2 (-C(CH3)2), 66.3 (C-5), 70.7 (C-2), 71.1 (C-3), 71.5 (C-4), 
90.6 (HetC-2), 96.5 (C-1), 109.2, 110.2 (-C(CH3)2), 124.7-131.3 (aromatics), 156.9 (C=N), 167.7 
(C=O). Anal. calcd. for C21H26N2O7: %C, 60.28; %H, 6.26; %N, 6.69. Found %C, 59.93; %H, 
6.60; %N, 6.50. 
(2S)-3-N-Acetyl-5-phenyl-2-[5-(1,2:3,4-di-O-isopropylidene-α-L-arabinopyranosyl)]-1,3,4-
oxadiazoline 3b: White solid, mp 142-145 °C; CCDC 892324;  Rf: 0.62 in 40% ethyl 
acetate/cyclohexane; [α]D20 -1.51 (c 0.84, CHCl3); 1H NMR (500 MHz, CDCl3) δΗ 1.17, 1.26, 
1.33, 1.57 (12 H, four s, -C(CH3)2), 2.35 (3H, s, -NCOCH3), 4.31 (1H, broad d, 3JHH 2.6 Hz, H-5) 
4.36 (1H, dd, 3JHH 2.5, and 3JHH 4.9 Hz, H-2), 4.37 (1H, dd, 3JHH 1.8 Hz and 3JHH 6.4 Hz, H-4), 
4.61 (1H, dd, 3JHH 2.4 Hz and 3JHH 7.8 Hz, H-3), 5.67 (1H, d, 3JHH  4.9 Hz, H-1), 6.52 (1H, d, 
3JHH 4.3 Hz, HetH-2); 13C NMR (125 MHz, CDCl3) δC 21.4 (-NCH3), 24.3, 25.0, 25.9, 26.1      
(-C(CH3)2), 65.5 (C-5), 70.0 (C-4), 71.0 (C-2 and C-3), 90.43 (HetC-2), 96.8 (C-1), 109.2, 109.8 
(-C(CH3)2), 124.8-131.5 (aromatics), 157.4 (C=N), 168.4 (C=O). Anal. calcd. for C21H26N2O7: 
%C, 60.28; %H, 6.26; %N, 6.69. Found %C, 60.03; %H, 6.56; %N, 6.65. 
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(2R)-3-N-Acetyl-5-methyl-2-[5-(1,2:3,4-di-O-isopropylidene-α-L-arabinopyranosyl)]-1,3,4-
oxadiazoline 4a: Light brown syrup, Rf: 0.32 in 40% ethyl acetate/cyclohexane; [α]D20 1.82 (c 
0.96, CHCl3); 1H NMR (500 MHz, CDCl3) δH 1.30, 1.38, 1.48, 1.49 (12 H, four s, -C(CH3)2), 
2.04 (3H, s, HetCH3), 2.23 (3H, s, -NCOCH3), 4.31 (1H, dd, 3JHH 2.0 Hz and 3JHH 1.0 Hz, H-5), 
4.33 (1H, dd, 3JHH 2.6, and 3JHH 5.0 Hz, H-2), 4.45 (1H, dd, 3JHH 1.8 Hz and 3JHH 7.9 Hz, H-4), 
4.64 (1H, dd, 3JHH 2.4 Hz and 3JHH 7.8 Hz, H-3), 5.52 (1H, d, 3JHH 4.8 Hz, H-1), 6.24 (1H, d, 
3JHH 1.0 Hz, HetH-2); 13C NMR (50 MHz, CDCl3) δC 11.3 (HetCH3), 21.3 (N-CH3), 24.9, 25.0, 
25.9 (-C(CH3)2), 66.3 (C-5), 70.8 (C-2), 71.0 (C-3), 71.5 (C-4), 90.0 (HetC-2), 96.5 (C-1), 109.3, 
110.3 (-C(CH3)2), 157.3 (C=N), 167.3 (C=O). Anal. calcd. for C16H24N2O7: %C, 53.92; %H, 
6.79; %N, 7.86. Found %C, 53.85; %H, 6.82; %N, 7.77. 
(2S)-3-N-Acetyl-5-methyl-2-[5-(1,2:3,4-di-O-isopropylidene-α-L-arabinopyranosyl)]-1,3,4-
oxadiazoline 4b: Light brown syrup, Rf: 0.45 in 40% ethyl acetate/cyclohexane; [α]D20 -2.38 (c 
0.91, CHCl3); 1H NMR (500 MHz, CDCl3) δΗ 1.32, 1.33, 1.47, 1.56 (12 H, four s, -C(CH3)2), 
2.03 (3H, s, HetCH3), 2.23 (3H, s, -NCOCH3), 4.21 (1H, dd, 3JHH 1.6 and 3JHH 4.0 Hz, H-5) 4.30 
(1H, dd, 3JHH 1.6 and 3JHH 8.1, H-4), 4.32 (1H, dd, 3JHH 2.4 Hz and 3JHH 4.8 Hz, H-2), 4.59 (1H, 
dd, 3JHH 2.4 Hz and 3JHH 8.1 Hz, H-3), 5.62 (1H, d, 3JHH 5.0 Hz, H-1), 6.30 (1H, d, 3JHH 4.0 Hz, 
HetH-2); 13C NMR (200 MHz, CDCl3) δC 11.5 (HetCH3), 21.3 (-NCOCH3), 24.3, 25.0, 25.9, 
26.1 (-C(CH3)2), 65.3 (C-5), 69.8 (C-4), 71.0 (C-2 and C-3),  89.9 (HetC-2), 96.8 (C-1), 109.2, 
109.7 (-C(CH3)2), 157.9 (C=N), 167.9 (C=O). Anal. calcd. for C16H24N2O7: %C, 53.92; %H, 
6.79; %N, 7.86. Found %C, 53.79; %H, 6.86; %N, 7.65. 
Microwave-assisted synthesis of compounds 4a and 4b. Compound 2 (0.4245 g, 1.3 mmol) 
were dissolved in pyridine (3.0 mL) in a microwave vessel and acetic anhydride (2.5 mL) was 
added. The sealed vessel with the mixture was heated at 140 °C with stirring (900 rpm) and the 
temperature was held for 60 min. Once cold, the mixture was transferred to a round bottom flask, 
some ethanol was added and the reaction medium was evaporated at reduced pressure, giving a 
glassy residue. The residue was purified as described previously and compounds 4a and 4b were 
obtained in a 68% yield (0.321 mg). 
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